Multiple sclerosis (MS) Nervous System Diseases Multiple sclerosis (MS)
Conditions
Interventions
Patients will be recruited nationwide through newspapers, self-help-group publications and the internet. Patients within a decision process about immunotherapy will be included. Those are either patie
Sponsors
University of Hamburg
Eligibility
Inclusion criteria
Inclusion criteria: Patients with multiple sclerosis who consider a new immunotherapy or who are willing to reconsider a decision (no selection of certain disease courses).
Exclusion criteria
Exclusion criteria: Patients with a major cognitive deficit and/or who do not agree to data check at health insurance companies are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint are the 'realized role preferences' defined as the difference between autonomy preferences (pre intervention) and performed autonomy (post appointment). A difference as small as possible is defined as the desirable outcome. Secondary endpoints include the number of continued, changed, interrupted, or newly started immunotherapies. Also, analyses of the 'shared decision process' and 'decision evaluation' are performed. We also look at a number of control parameters (eg. other information sources, time to initiation of treatment, control beliefs, etc.) and clinical variables (disability status and disease activity). | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Germany
Outcome results
None listed